Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.

Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C.

Lancet. 2009 Dec 19;374(9707):2115-22. doi: 10.1016/S0140-6736(09)61877-8. Epub 2009 Oct 31. Erratum in: Lancet. 2010 Jan 30;375(9712):376.

PMID:
19880172
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group.

Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13.

PMID:
23498095
[PubMed - indexed for MEDLINE]
3.

The expected number of background disease events during mass immunization in China.

Wang Y, Wu L, Yu X, Zhao F, Russell A, Song M, Wang W.

PLoS One. 2013 Aug 20;8(8):e71818. doi: 10.1371/journal.pone.0071818. eCollection 2013.

PMID:
23977153
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.

Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M; VAESCO-GBS Case-Control Study Group.

BMJ. 2011 Jul 12;343:d3908. doi: 10.1136/bmj.d3908.

PMID:
21750072
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations.

Banzhoff A, Haertel S, Praus M.

Hum Vaccin. 2011 May;7(5):539-48. Epub 2011 May 1.

PMID:
21422814
[PubMed - indexed for MEDLINE]
Free Article
6.

Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.

Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F.

BMJ. 2011 Oct 12;343:d5956. doi: 10.1136/bmj.d5956.

PMID:
21994316
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Estimating background rates of Guillain-Barré Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1/09 immunization campaign.

Deeks SL, Lim GH, Simpson MA, Rosella L, Mackie CO, Achonu C, Crowcroft NS.

BMC Public Health. 2011 May 17;11:329. doi: 10.1186/1471-2458-11-329.

PMID:
21586163
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.

Verity C, Stellitano L, Winstone AM, Stowe J, Andrews N, Miller E.

Arch Dis Child. 2014 Jun;99(6):532-8. doi: 10.1136/archdischild-2013-304475. Epub 2014 Feb 28.

PMID:
24585755
[PubMed - indexed for MEDLINE]
9.

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H; Global H1N1 GBS Consortium.

Vaccine. 2013 Sep 13;31(40):4448-58. doi: 10.1016/j.vaccine.2013.06.032. Epub 2013 Jun 14.

PMID:
23770307
[PubMed - indexed for MEDLINE]
10.

Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Jun 4;59(21):657-61.

PMID:
20520590
[PubMed - indexed for MEDLINE]
Free Article
11.

Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.

Andrews N, Stowe J, Al-Shahi Salman R, Miller E.

Vaccine. 2011 Oct 19;29(45):7878-82. doi: 10.1016/j.vaccine.2011.08.069. Epub 2011 Aug 27.

PMID:
21875631
[PubMed - indexed for MEDLINE]
12.

Guillain-Barré syndrome after exposure to influenza virus.

Lehmann HC, Hartung HP, Kieseier BC, Hughes RA.

Lancet Infect Dis. 2010 Sep;10(9):643-51. doi: 10.1016/S1473-3099(10)70140-7. Review.

PMID:
20797646
[PubMed - indexed for MEDLINE]
13.

Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series.

Crawford NW, Cheng A, Andrews N, Charles PG, Clothier HJ, Day B, Day T, Gates P, Macdonell R, Roberts L, Rodriguez-Casero V, Wijeratne T, Kiers L.

Med J Aust. 2012 Nov 19;197(10):574-8. Erratum in: Med J Aust. 2014 Apr 7;200(6):321. Macdonnell, Richard [corrected to Macdonell, Richard].

PMID:
23163689
[PubMed - indexed for MEDLINE]
14.

Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, Ho DT, Sheikh SI, Fireman BH, Daley MF, Belongia EA, Jacobsen SJ, Baxter R, Lieu TA, Kulldorff M, Vellozzi C, Lee GM.

Am J Epidemiol. 2012 Jun 1;175(11):1100-9. doi: 10.1093/aje/kws195. Epub 2012 May 11.

PMID:
22582210
[PubMed - indexed for MEDLINE]
Free Article
15.

Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010.

Yih WK, Lee GM, Lieu TA, Ball R, Kulldorff M, Rett M, Wahl PM, McMahill-Walraven CN, Platt R, Salmon DA.

Am J Epidemiol. 2012 Jun 1;175(11):1120-8. doi: 10.1093/aje/kws197. Epub 2012 May 11.

PMID:
22582207
[PubMed - indexed for MEDLINE]
Free Article
16.

Invited commentary: Influenza vaccine and Guillain-Barre syndrome--is there a risk?

Nelson KE.

Am J Epidemiol. 2012 Jun 1;175(11):1129-32. doi: 10.1093/aje/kws194. Epub 2012 May 11.

PMID:
22582208
[PubMed - indexed for MEDLINE]
Free Article
17.

Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.

Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Danila R, Giambrone GP, Hale C, Hogan BC, Meek JI, Murphree R, Oh JY, Reingold A, Tellman N, Conner SM, Singleton JA, Lu PJ, DeStefano F, Fridkin SK, Vellozzi C, Morgan OW.

Am J Epidemiol. 2012 Jun 1;175(11):1110-9. doi: 10.1093/aje/kws196. Epub 2012 May 11.

PMID:
22582209
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[Safety and epidemiological effects of the first China-made mass A (H1N1) influenza vaccination].

Ji WY, Lu L, Lü M, Miao L, Gao T, Huang RG, Suo LD, Liu DL, Ma R, Yu R, Zhangzhu JZ, Liu WX, Zeng Y, Li XM, Wu J.

Zhonghua Liu Xing Bing Xue Za Zhi. 2010 May;31(5):481-4. Chinese.

PMID:
21163019
[PubMed - indexed for MEDLINE]
19.

[Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].

Ormen B, Türker N, Vardar I, Kaptan F, El S, Ural S, Kaya F, Coşkun NA.

Mikrobiyol Bul. 2012 Jan;46(1):57-64. Turkish.

PMID:
22399172
[PubMed - indexed for MEDLINE]
20.

Pregnancy and safety outcomes in women vaccinated with an AS03-adjuvanted split virion H1N1 (2009) pandemic influenza vaccine during pregnancy: a prospective cohort study.

Tavares F, Nazareth I, Monegal JS, Kolte I, Verstraeten T, Bauchau V.

Vaccine. 2011 Aug 26;29(37):6358-65. doi: 10.1016/j.vaccine.2011.04.114. Epub 2011 May 17.

PMID:
21596080
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk